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WE have recently described the purification of a
54kDa acidic protein, identified as macrophage-
derived neutrophil chemotactic factor (MNCF).
This protein causes in vitro chemotaxis as well as
in vtvo neutrophil migration even in animals
treated with dexamethasone. This in vtvo chemo-
tactic activity ofMNCF in animals pretreated with
dexamethasone is an uncommon characteristic
which discriminates MNCF from known chemo-
tactic cytokines. MNCF is released in the super-
natant by macrophage monolayers stimulated
with lipopolysaccharide (LPS). In the present
study, we describe some biological characteristics
of homogenous purified MNCF. When assayed in
vitro, MNCF gave a bell-shaped dose-response
curve. This in vitro activity was shown to be
caused by haptotaxis. Unlike N-formyl-methionyl-
leucyl-phenylalanine (FMI) or interleukin 8
8), the chemotactic activity ofMNCF in vtvo and in
vitro, was inhibitedby preincubation with v-galac-
tose but not with D-mannose. In contrast with IL-8,
MNCF did not bind to heparin and antiserum
against IL-8 was ineffective in inhibiting its che-
motactic activity. These data indicate that MNCF
induces neutrophil migration through a carbohy-
drate recognition property, but by a mechanism
different from that of the known chemokines. It is
suggested that MNCF may be an important
mediator in the recruitment of neutrophils via the
formation of a substrate bound chemotactic
gradient (haptotaxis) in the inflamed tissues.
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Introduction
Emigration of neutrophils from the circulating
blood to the site of the injury is a cardinal event
during the inflammatory process. This phenom-
enon is complex and mediated by various mol-
ecules acting in different ways. Interleukin 1 and
8 (IL-1, IL-8), tumour necrosis factor (TNF), and
the complement fragments and leukotriene B4
(LTB4) are macrophage products thought to be
involved in the migration of neutrophils to the
inflamed site, a phenomenon characteristic of the
acute phase of the inflammatory process.
2-5
Some products such as C5a and LTB4 may have
a direct chemotactic effect on neutrophils.
6-8
Others may act indirectly by mechanisms which
depend on the tissue’s resident cells and on the
endothelium. For example, in addition to their
effects on neutrophils and endothelial cells,
where they increase the expression of adhesion
molecules, IL-1 and TNF also stimulate the
release of chemotactic factors by resident macro-
phages,
il In fact, the neutrophil-induced migra-
tion into the peritoneal cavity by cytokines such
as IL-1 and TNF, as well as various inflammatory
stimuli (LPS, carrageenin, etc), is dependent
on the number of resident cells. This idea is
supported by the alteration in the magnitude of
the neutrophil migration induced by various
stimuli when the resident cell population in the
peritoneum is increased by previous treatment
with thioglycollate or reduced by cell deple-
tion.11,14-17
Glucocorticoids greatly reduce the neutrophil
migration induced by inflammatory stimuli or by
cell-dependent chemotactic cytokines. The
mechanism by which glucocorticoids inhibit cell
migration is still controversial. There are some
indications that these substances block the
expression of adhesion molecules in the endo-
thelium,la However, there is also evidence that
glucocorticoids may not have a direct effect on
the expression of these proteins in neutrophils
or endothelial cells but instead may block the
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release of the mediators involved in the final rats pretreated or not with glucocorticoids, or in
stage of neutrophil emigration into tissue.19’2 vitro for their ability to induce neutrophil migra-
In the companion paper
2 we describe the iso- tion in a microchamber in the presence of either
lation of a homogeneous protein which, like anti-IL-8 serum or of control serum.
crude MNCF, induced neutrophil migration in
vitro as well as in vivo even in animals pre- Determination ofbiological activity:
treated with dexamethasone. The purified factor
was acidic and had a molecular mass of 54 kDa. In vivo migration assays. MNCF activity was
In the present study, we describe some biologi- assayed by its ability to induce neutrophil migra-
cal characteristics of this purified homogeneous tion into the peritoneal cavity or air pouch of
MNCF fraction associated with their neutrophil rats pretreated with a glucocorticoid (0.5 mg of
chemoattractant activity in vivo and in vitro, dexamethasone acetate ester/kg, subcutaneously;
These activities are dependent upon the carbohy- Merck, Darmstadt, Germany). Each sample was
drate recognition property of MNCF. tested in groups of five to six rats. Air pouches
were produced on the dorsum of rats as describ-
ed by Edwards et a/.23 One h after dex-
Materials and Methods amethasone, 1 or 3 ml samples were injected into
the air pouch or peritoneal cavity, respectively.
Animals: Male, albino, Wistar rats (Rattus norve- The animals were sacrificed by cervical disloca-
gicus) weighing from 180 to 200g and main- tion 4 or 6 h later for the peritoneal or air pouch
tained in temperature-controlled rooms at 23- tests, respectively. The cells were immediately
25C with free access to food and water, were harvested by washing the respective cavities with
used as the source of peritoneal macrophages as 5 or 10ml PBS containing albumin (0.1%w/v)
well as for the in vivo tests of cell migration, and heparin (5 IU/ml). Total counts of harvested
cells were performed in a Neubauer chamber.
Production and purification of neutrophil chem- Differential counts were made on smears stained
otactic factor (MNCF): MNCF was produced and using Rosenfeld’s panchromic method. The
purified as described by Cunha and Ferreira, and results are reported as the mean number
Dias-Baruffi et al. 14,22 Briefly, the supernatant (4- S.E.M.) of neutrophils per ml of cavity wash.
from LPS-stimulated macrophage monolayers To test the inhibitory effect of D-galactose or
(crude MNCF) were submitted to a simple two- )-mannose on the neutrophil migration induced
step purification process involving adsorption to by MNCF or other stimuli, the samples were
a )-galactose column followed by gel filtration incubated with these sugars (final concentration
on Superdex 75, for the isolation of MNCF. In 0.4M) for 30 min at room temperature. The neu-
the present paper MNCF refers to the homo- trophil migration activity of the stimuli was then
geneous fraction obtained after the last purifica- tested in the air pouch model as described
tion step. above.
Heparin binding assay of MNCE. Binding to In vitro neutrophil chemotaxis migration assay.
heparin was assessed with a heparin-agarose Assays of in vitro neutrophil migration were per-
column. The column was washed and equilib- formed as described by Bignold
24 in a 48-well
rated with PBS. Three ml of crude MNCF derived chemotactic microchamber (Neuroprobe, Cabin
from 4.2 x 108 cells were applied to a 4ml John, MD, USA). Human neutrophils were iso-
column of heparin-agarose (Sigma Chemical lated from the heparinized peripheral blood of
Company, St. Louis, MO, USA) at 4C. The mate- healthy human volunteers using mono poly
rial not retained by the column after washing resolving medium (Flow laboratories, Rock,lie,
with PBS was denoted as the heparin-not-bound MD, USA). After washing with RPMI 1640
fraction while that retained and eluted with 0.5M medium, the neutrophils were resuspended in
NaCl in PBS was denoted heparin-bound. Both RPMI 1640 medium containing 0.1% (w/v) BSA
fractions were applied to a Fast Desalting HR 10/ (RPMI-BSA), to provide 106 cells/ml. Typical pre-
10 column (Pharmacia LKB Biotechnology, parations contained more than 95% viable neu-
Uppsala, Sweden). The column was developed trophils. Purified neutrophils were placed in the
with sterile deionized water at 20C and a flow upper chamber while the lower chamber con-
rate of 0.5ml/min. The eluate absorbance was tained the test samples dissolved in RPMI-BSA.
monitored at 206 and 280nm, and fractions of Random migration was assessed by using RPMI-
0.5 ml were collected. These fractions were then BSA in the lower chamber. The peptide FMLP
tested either in vivo for their ability to induce (10-7M) was used as the reference chemoat-
neutrophil migration into the peritoneal cavity of tractant. The number of cells that migrated
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through the entire thickness of a 5/.tm poly-
carbonate filter (Millipore Corp., Bedford, MA,
USA) during the i h incubation at 37C in a 5%
COg atmosphere was counted. Five fields were
counted for each assay and each sample was
assayed in triplicate. The results are reported as
the mean number (_+ S.E.M.) of neutrophils per
field. The samples tested were crude MNCF,
purified MNCF or human recombinant inter-
leukin-8 (rhIL-8; from National Institute for Bio-
logical Standards and Control-NIBSC) as well as
the heparin-bound and heparin-not-bound frac-
tions of the LPS-stimulated macrophage super-
natant. Crude MNCF, purified MNCF or rhIL-8
were incubated in medium with )-galactose or D-
mannose (0.4M in RPMI-BSA) for 30 min at
room temperature before testing the effect of
)-galactose or D-mannose on the chemotactic
activity of each sample. The heparin-bound and
heparin-not-bound fractions, as well as rhlL-8,
were incubated separately in medium containing
anti-IL-8 goat serum or control goat serum (final
dilutions 1:100 and 1:10 in RPMI-BSA) for 30
min at room temperature before testing the
effect of anti-IL-8 on the chemotactic activity of
each sample.
In vitro neutrophil haptotaxis assay. The hapto-
taxis assay was conducted as described by Rot25
in a 48-well chemotactic chamber (Neuroprobe)
by forming a gradient across a 51.tm poly-
carbonate filter (Millipore Corp.) Positive hapto-
tactic gradients of MNCF were preformed by
filling some of the bottom wells with purified
MNCF derived from 3.6 x 107 ceils and the cor-
responding top wells with RPMI-BSA. Negative
haptotactic gradients were obtained by reversing
the above procedure, i.e., by filling a set of top
wells with MNCF derived from 3.6 x 107 cells
and the corresponding bottom wells with RPMI-
BSA. When chemotaxis, chemokinesis or random
migration were examined, both the upper and
lower wells were filled with RPMI-BSA. After
incubation at 37C for 20 min, the chambers
were disassembled. The filter was thoroughly
washed in an RPMI-BSA bath to remove the non-
bound attractant, after which it was air dried and
placed in another chemotactic chamber. In this
second chamber, RPMI-BSA was used to fill the
bottom wells corresponding to those wells with
preformed positive or negative gradients in the
first chamber. The wells corresponding to those
that did not contain attractant in the first
chamber were used to assess chemotaxis (by
adding the attractants MNCF or FMLP (10- 7M)
to the bottom chamber), chemokinesis (by
adding equal quantities of MNCF to both the top
and bottom chambers), or random migration (by
adding RPMI-BSA to both the top and bottom
chambers). Fifty l.tl of a suspension of 10 neut-
rophils/ml were placed in each top well of the
second chamber, and their migration was meas-
ured by counting the cells that migrated into or
towards the second chamber across the filter
during a 30 min incubation at 37C. Five fields of
filters were counted for each assay and each
sample was assayed at least in triplicate. The
results are reported as mean 4- S.E.M.
Results
Biological characterization of chemotactic activ-
ities ofMNCE. Purified MNCF induced neutrophil
migration in the same dose-dependent manner in
both normal and dexamethasone-pretreated rats
(Fig. 1A). The dose-response curve obtained for
the in vitro chemotactic activity of purified
MNCF was bell-shaped (Fig. 1B). The chemotac-
tic activity was shown to result from haptotaxis
rather than chemokinesis since the neutrophil
chemokinetic migration induced by purified
MNCF was similar to that of a negative control.
While in vitro neutrophil migration was observed
with a positive haptotactic gradient with MNCF,
the negative haptotactic gradient of MNCF was
unable to induce neutrophil migration (Fig. 2).
These data indicate that the neutrophil migration
induced by filter-bound MNCF was gradient-
driven.
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FIG. 1. Dose-response curves for the in vivo and in vitro neutro-
phil migration induced by purified MNCF. Panel A: Neutrophil
migration into the peritoneal cavity of normal (open bars) or
dexamethasone-pretreated rats (0.5mg/kg; filled bars)induced
by purified MNCF at the dilutions indicated. The quantity of
MNCF injected per rat at 1:1 dilution was obtained from
1.4 x 107 macrophages. PBS was also injected. Neutrophil
migration was evaluated 4h after the injection of MNCF. The
results are the mean number (-I- S.E.M.) of neutrophils per ml of
peritoneal wash (n six rats/group). Panel B: Neutrophil chemo-
taxis in vitro induced by purified MNCF at the dilutions indicated.
The quantity of MNCF used in the initial dilution was obtained
from 3.6 x 107 macrophages. The number of purified human
neutrophils used was 106 cells/well. The assay was carried out
in triplicate. Migration was evaluated after h. The results are
the mean number (4- S.E.M.) of neutrophils per field (15 fields).
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1=1(3. 2. Purified MNC1= induces neutrophil migration in vitro by
chemotactic and haptotactic gradients. The chemotactic activity
of purified MNCF (from 1.4 107 macrophages/well) was tested
in a 48-well microchamber. The in vitro chemotactic (CT), chemo-
kinetic (CK), positive haptotactic (H+) and negative haptotactic
(H-) activities were determined as described in the Materials and
Methods. The RPMI 1640 medium and FMLP (10
-7 M) were
used as negative and positive controls, respectively. The number
of purified human neutrophils used was 106 cells/well and, the
assay was carried out in triplicate. The results are the mean
number (+ S.E.M.) of neutrophils per field (15 fields).
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FIG. 3. The effect of D-galactose and D-mannose on the in vitro
neutrophil migration induced by different stimuli. FMLP
(10-7M), IL-8 (10-7M), crude MNCF (from 2 x 106 macro-
phages), and purified MNCF (from 1.4 x 107 macrophages)
were incubated with RPMI 1640 (open bars) or with D-galactose
(D-gal; filled bars; panel A) or o-mannose (D-man; cross hatched
bars; panel B) at a concentration of 0.4M for 30 min and the
resulting chemotactic activity was evaluated in a 48-well micro-
chamber. RPMI 1640 either D-gal or D-man were used as nega-
tive controls. The number of purified human neutrophils used
was 106 cells/well and the assay was carried out in triplicate.
Migration was evaluated after h. The results are the mean
number (+ S.E.M.) of neutrophils per field (15 fields).
Table 1 shows that pretreating the test animals
with dexamethasone blocked the neutrophil
migration induced by the heparin-bound fraction
and by rhlL-8. However, as with the results
obtained for purified MNCF (Fig. 1), this treat-
ment did not affect the neutrophil migration
induced by the heparin-not-bound fraction. In
the in vitro assay, the chemotactic activity of the
heparin-bound fraction was inhibited by pre-
incubation with anti-IL-8 serum. A similar result
was observed with rhlL-8. On the other hand, the
in vitro chemotactic activity of the heparin-not-
bound fraction was not affected by the same
amount of anti-IL-8 serum.
Relationship between migration-inducing and
carbohydrate-binding activities: Fig. 3A shows
that 0.4M D-galactose did not affect the chemo-
tactic activity of FMLP or IL-8 in vitro, but did
inhibit the activity of purified MNCF by more
than 90%. As expected, the chemotactic activity
of crude MNCF was only partially reduced (28%)
by the same concentration of D-galactose. At the
same concentration, a non-specific sugar ()-
mannose) had no effect on the chemotactic
activities of FMLP or purified MNCF (Fig. 3B).
The incubation of crude or purified MNCF
with D-galactose (0.4 M) also inhibited the ability
to induce neutrophil migration into the air pouch
Table 1. The effect of dexamethasone or anti-lL-8 serum on the chemotactic activities of heparin-bound and heparin-not-bound
fractions of LPS-stimulated macrophage supernatants
/n vivo assay In vitro assay
Neutrophils x 106 Inhibition (%) Neutrophils/field Inhibition (%)
PBS Dexamethasone Control serum Anti-lL-8 serum
pretreatment pretreatment
Medium 0.2 -t- O. 0.2 +_ O. 0 182.0 181.9 0
rhlL-8 2.4 +_ 0.4 0.4 +_ 0.1 83 603.3 201.4 67
Heparin-bound 3.1 -i- O. 1.1 -i- O. 64 754.1 443.9 42
Heparin-not-bound 1.8 -t- O. 1.8 -t- 0.3 0 604.8 664.2 0
aln vivo assay: the migration of neutrophils into the peritoneal cavity of rats, pretreated or not with dexamethasone (0.5 mg/kg/s.c., h previously) in
response to human recombinant interleukin 8 (rhlL-8; 7.5 moles) or heparin-bound or heparin-not-bound fractions of LPS-stimulated macrophage
supernatants (derived from 1.4 x 107 cells). The number of neutrophils is reported as the mean number S.E.M. of cells per ml of peritoneal wash for five
animals. PBS was used as the medium control.
bin vitro assay: the chemotactic activities of rhlL-8 (30 nM) or heparin-bound or heparin-not-bound fractions of LPS-stimulated macrophage supernatants
(derived from 4.5 x 10 cells per well) preincubated with control goat serum (1:10) or anti-lL-8 goat serum (1:10) were assayed as described in the
Materials and Methods. A 1:100 dilution of both sera was ineffective. The data are reported as the mean S.E.M. of three determinations. RPMI was used
as the medium control.
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Table 2. Effect of D-galactose and D-mannose on migration in
vivo induced by MNCF
In vivo assay
Inhibition (%)
By By
D-mannose o-galactose
Medium 6 0
Crude MNCF 0 40
Purified MNCF 11 46
Crude MNCF (from 3 x 10 macrophages), or purified MNCF (from
x 10 macrophages) previously non-incubated or incubated with D-
galactose or D-mannose (final concentration 0.4 M), was injected into the
air pouches of dexamethasone-pretreated rats (0.5 mg/kg). Neutrophil
migration was evaluated 4h later. The results represent the percentage
inhibition compared with the migration induced by the same stimulus
when non-incubated with D-mannose or D-galactose and incubated with
each sugar.
of dexamethasone-pretreated rats by 40 and 46%,
respectively. At the same concentration, a non-
specific sugar (>mannose) had no effect on the
in vivo or in vitro chemotactic activity of crude
or purified MNCF (Table 2).
Discussion
In a companion paper,
21 we have described
the purification to homogeneity of a .54kDa
acidic protein extracted from the supernatant of
LPS-stimulated macrophage monolayers. Like the
crude macrophage-derived neutrophil chemo-
tactic factor (MNCF), this protein was able to sti-
mulate neutrophil migration in animals pretreated
14 21 with dexamethasone. This in vivo chemo-
tactic activity is an uncommon cytokine char-
acteristic and seems peculiar to MNCF. MNCF
behaves like a lectin on the basis of its ability
to bind to immobilized )-galactose and the
inhibition of its biological activity by the same
sugar.
22
In line with our previous observations for
crude MNCF, the isolated protein induced dose-
dependent neutrophil migration in vivo in naive
and as well as in dexamethasone-pretreated
animals. >galactose, but not )-mannose, sig-
nificantly inhibited (46%) the capacity of purified
MNCF to induce neutrophil migration in viva
This limited inhibitory effect of D-galactose in the
in vivo assay may reflect the diffusion and/or the
reabsorption of the sugar from the air pouch
cavity during the 6 h required for the neutrophil
migration test.
MNCF also caused chemotaxis in vitro with
the dose-response being similarly bell-shaped to
that described for other chemotactic agents such
as FMLP and LTB4,
26 i>mannose-bindin/_ lectin
from Artocarpus integrifolia (KM ) and
IL-8.25 The decreased activity observed with high
doses of the factor may result from its diffusion
into the upper compartment of the chamber,
thereby abolishing the chemoattractant gradient.
The in vitro chemotactic activity of MNCF was
strongly inhibited by pre-incubation with ,)-galac-
tose. This inhibition appears to be specific for
MNCF since pre-incubation of FMLP or IL-8 with
the same concentration of I)-galactose did not
affect their chemotactic activity. Pre-incubation
with a non-related sugar, >mannose, did not
modify the activity of MNCF or FMLP. The crude
MNCF was only partially inhibited by )-galactose
since other chemotactic mediators such as IL-1,
TNF and IL-85’28 were also present. These results
support the suggestion that MNCF activity in
vitro and in vivo is associated with a sugar-
binding domain of the purified protein.
There are at least three distinct stages in the
process of neutrophil migration into perivascular
tissues: (1) neutrophil adhesion to the endothe-
lial cells mediated by endothelium-expressed
selectins and ICams,29’3; (2) PECAM-l-mediated
neutrophil penetration through endothelial cell
3132 juncuons; and (3) neutrophil migration
across the basal membrane into perivascular
tissues.9’2 Haptotaxis is thought to be an
important mechanism throughout this whole
process. Binding of the chemoattractant on the
subendothelial matrix is required for the forma-
tion of a haptotactic gradient. In the present
paper, we have shown that MNCF causes in vitro
chemotaxis by both chemotactic and haptotactic
mechanisms, properties shared by IL-8.25
However, in contrast to IL-8, MNCF did not bind
to heparin and its chemotactic activity was
blocked by -galactose but not by anti-IL-8 serum
(Table 1). Thus, the sugar binding moiety which
is involved in the stimulation of neutrophil che-
motaxis by MNCF is different from that involved
in IL-8-induced chemotaxis.
Early in vivo experiments suggested that the
inhibitory effect of glucocorticoids on neutrophil
migration was due to an action on the neutro-
phil-endothelium adhesion step.4- There are,
however, conflicting results regarding the inhibi-
tory effect of glucocorticoids on the foregoing
interaction in vitro37 and on the expression of E-
selectin and 1CAM-1.
8 Recent in vivo monitoring
of the different stages of neutrophil migration
has shown that the rolling on or adhesion to
venular endothelium induced by LTB4 or FMLP
was not inhibited by pretreating the animals with
0 dexamethasone. In addition, glucocorticoid
treatment did not inhibit neutrophil penetration
via the endothelial cell junctions, although it was
noted that the neutrophils subsequently
remained between the endothelium and the basal
membrane without reaching the perivascular
Mediators of Inflammation Vol 4 1995 267M. Dias-Baru et al.
tissue.19’2 From these experiments it is clear that
glucocorticoids affect neutrophil migration
mainly by inhibiting an unidentified mechanism
responsible for the transmigration through the
basal membrane to the perivascular tissue.
The obseeeation that dexamethasone does not
affect MNCF-induced chemotaxis in vivo but
does block the migration induced by IL-8 allows
one to speculate about distinct mechanisms
involved in the neutrophil migration induced by
both cytokines. MNCF-induced chemotaxis in
vivo must result from the protein’s ability to
promote the three stages of neutrophil emigra-
tion to tissues described above. IL-8-induced
chemotaxis in vivo, however, may result from
mechanisms involving a dexamethasone-sensitive
release of chemotactic factors by resident cells
such as mast cells5 and/or the formation of a
haptotactic gradient.25’38 In relation to the gen-
eration of the haptotactic gradient, IL-8 and
MNCF may recognize different ligands on the
subendothelial matrix, and glucocorticoids may
be able to block the expression of the IL-8
ligand while not affecting that of MNCF. The
hypothesis of different ligands for IL-8 and MNCF
is reinforced by the fact that MNCF, in contrast
to IL-8 did not bind to heparin (Table 1), which
is structurally related to heparan sulfate.39
Heparan sulfate has been proposed to be the
extracellular matrix ligand for IL-8 responsible
for inducing neutrophil migration by the hapto-
tactic mechanism.9-1
Based on the results of this study, we hypothe-
size that MNCF forms a dexamethasone-insensi-
tive substrate bound gradient (haptotactic
gradient) responsible for the last phase of
neutrophil emigration through the basal mem-
brane of acutely inflamed tissues. The previously
reported dexamethasone blockade of the release
of MNCF by macrophage monolayers stimulated
by inflammatory stimuli
4 may at least in part
explain why the last phase of neutrophil migra-
tion is impaired in dexamethasone pretreated
animals.
In conclusion, a 54kDa acidic protein, identi-
fied as macrophage-derived neutrophil chemotac-
tic factor (MNCF), has lectin-like properties and
causes neutrophil migration in vivo in animals
treated with dexamethasone, as well as neu-
trophil chemotaxis in vitro by a haptotactic
mechanism. MNCF is a candidate for a new cyto-
kine and may play an important role in the trans-
migration of neutrophils to perivascular tissues.
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